Stockscreener 앱 받기
19.82
4.15%
-0.805
전일 마감가:
$20.62
열려 있는:
$20.27
하루 거래량:
766.46K
Relative Volume:
0.70
시가총액:
$916.26M
수익:
$82.71M
순이익/손실:
$-102.24M
주가수익비율:
-5.3992
EPS:
-3.67
순현금흐름:
$-76.57M
1주 성능:
-2.06%
1개월 성능:
+13.59%
6개월 성능:
+71.72%
1년 성능:
+65.67%
1일 변동 폭
$19.50
$20.58
1주일 범위
$19.17
$21.48
52주 변동 폭
$3.42
$21.71
Urogen Pharma Ltd Stock (URGN) Company Profile
명칭
Urogen Pharma Ltd
전화
972 9 770 7601
주소
9 HA'TA'ASIYA ST, RA'ANANA
URGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
URGN
Urogen Pharma Ltd
|
19.80 | 953.97M | 82.71M | -102.24M | -76.57M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.71 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.74 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.50 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.64 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.63 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Urogen Pharma Ltd Stock (URGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-06-16 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-05-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-04-16 | 개시 | Scotiabank | Sector Outperform |
| 2025-02-19 | 재개 | Ladenburg Thalmann | Buy |
| 2024-08-22 | 개시 | Guggenheim | Buy |
| 2023-02-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-04-27 | 개시 | Berenberg | Buy |
| 2020-04-16 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-13 | 재확인 | H.C. Wainwright | Buy |
| 2020-01-09 | 개시 | National Securities | Neutral |
| 2019-05-30 | 개시 | JP Morgan | Neutral |
| 2019-05-29 | 개시 | Goldman | Neutral |
| 2019-01-29 | 개시 | H.C. Wainwright | Buy |
| 2018-11-08 | 재개 | Jefferies | Buy |
| 2018-04-04 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-01-02 | 개시 | Ladenburg Thalmann | Buy |
| 2017-11-15 | 재확인 | Oppenheimer | Outperform |
| 2017-11-15 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
모두보기
Urogen Pharma Ltd 주식(URGN)의 최신 뉴스
Urogen Pharma Ltd expected to post a loss of 69 cents a shareEarnings Preview - TradingView
Does UroGen Pharma Ltd. show high probability of rebound2025 Price Targets & Free Technical Confirmation Trade Alerts - newser.com
UroGen Pharma to Present at Guggenheim Securities Healthcare Innovation Conference - The Manila Times
Is UroGen Pharma Ltd. (UR8) stock prepared for digital transitionRate Hike & Fast Exit Strategy with Risk Control - newser.com
Why UroGen Pharma Ltd. stock could be next big winnerJuly 2025 Intraday Action & Daily Profit Focused Screening - newser.com
Automated trading signals detected on UroGen Pharma Ltd.Quarterly Profit Report & Fast Entry Momentum Trade Alerts - newser.com
How UroGen Pharma Ltd. stock compares to industry benchmarksQuarterly Investment Review & Weekly Breakout Stock Alerts - newser.com
Using data tools to time your UroGen Pharma Ltd. exit2025 Trading Recap & Low Risk High Win Rate Picks - newser.com
Is UroGen Pharma Ltd. (UR8) stock worth holding before Fed meetingEarnings Beat & Daily Technical Stock Forecast Reports - newser.com
Applying Elliott Wave Theory to UroGen Pharma Ltd.July 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Harel Insurance Investments & Financial Services Ltd. Has $2.16 Million Holdings in Urogen Pharma $URGN - MarketBeat
Can UroGen Pharma Ltd. stock withstand economic slowdown2025 Earnings Surprises & Daily Technical Stock Forecast Reports - newser.com
Why UroGen Pharma Ltd. (UR8) stock stays on buy listsJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
Can UroGen Pharma Ltd. stock resist sector downturnsJuly 2025 Patterns & Weekly Top Stock Performers List - newser.com
UroGen: Expect Rough Patch Before Strong Recovery In 2026 (NASDAQ:URGN) - Seeking Alpha
Is UroGen Pharma Ltd. stock bottoming outPortfolio Growth Summary & Community Verified Trade Signals - newser.com
How UroGen Pharma Ltd. stock reacts to job market dataJuly 2025 Setups & Trade Opportunity Analysis Reports - newser.com
Is UroGen Pharma Ltd. (UR8) stock undervalued after correctionMarket Weekly Review & Intraday High Probability Setup Alerts - newser.com
What indicators show strength in UroGen Pharma Ltd.Gold Moves & Safe Capital Allocation Plans - newser.com
How UroGen Pharma Ltd. (UR8) stock behaves in tightening cyclesJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
What analysts say about UroGen Pharma Ltd stockPrice Volatility Patterns & High Return Stock Ideas - earlytimes.in
UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025 - The Manila Times
Migdal Insurance & Financial Holdings Ltd. Reduces Position in Urogen Pharma $URGN - MarketBeat
Published on: 2025-10-30 00:50:10 - newser.com
Urogen Pharma Ltd (URGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):